Skip to content

Clarus Spinepen Model 2126

by Clarus Medical Systems, Inc.

510(k) K955598

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK955598 Date6 Feb 1996ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
GWG
Device Class
Class II
Regulation
21 CFR Part 882.1480
Advisory Committee
Neurology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The device is an Endoscope, Neurological, as defined in the device data. It is identified as the Clarus Spinepen Model 2126.

It received FDA 510(k) clearance (K955598) on February 6, 1996, and is classified as a Class II device under regulation number 882.1480. The device is used in the field of Neurology and was found substantially equivalent to a predicate device.

Other devices from Clarus Medical Systems, Inc.

See all devices from Clarus Medical Systems, Inc. →

Questions

AI-generated answers, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Clarus Spinepen Model 2126 used for?

    The Clarus Spinepen Model 2126 is an endoscope designed for neurological procedures, as indicated by its classification under regulation number 882.1480 and its assignment to the Neurology medical specialty. It was found substantially equivalent to a predicate device, meaning it performs the same neurological endoscopic functions as previously cleared devices.

  • How was the Clarus Spinepen Model 2126 authorized for market release?

    The device received FDA 510(k) clearance under submission number K955598 on February 6, 1996, through a traditional review process. This authorization pathway confirms it is substantially equivalent to a legally marketed predicate device, allowing it to be sold in the United States for its intended neurological endoscopic use.

  • What regulatory classification applies to the Clarus Spinepen Model 2126?

    The Clarus Spinepen Model 2126 is classified as a Class II medical device under FDA regulation number 882.1480, which governs neurological endoscopes. This classification reflects its moderate risk level and the general and special controls required to ensure its safety and effectiveness in neurological applications.